SYK
Stryker Corporation
$341.18
▲ +4.75%
+$15.48
NYSE · Healthcare · Medical Devices
· price updated 9h ago
Stryker Corporation
SYK · NYSE · Healthcare · Medical Devices · price updated 9h ago
$341.18
▲ +4.75% · +$15.48 today
AI research · $341.18
SYK, researched
Stryker's Q2 Earnings Beat Expectations Amid Revenue Concerns
refreshed Jul 30
price position
Where SYK sits now
52-week range
Low$281.00
High$403.22
Today $341.18
RSI (14)
61.8Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$3.5B
Total debt$14.9B
Net cash after debt$-11.5B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 11% above Sector avg
20.32x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
4.84x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
26.57x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
20.27x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
12.5%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
16.5%
Debt / equity
Balance-sheet leverage
Favorable · Ahead of most sector peers
0.64x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.16x
Geographic mix
Mar 31, 2026United States75.3% · $19.0B
International24.6% · $6.2B
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How SYK compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $124.86B | 33.8 | +8.5% | 64 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Stryker Corporation (SYK) stock
Stryker Corporation tracked in the US core universe. SYK was +4.8% in the latest available session at $341.18. Its reported market value was $124.86B with a trailing P/E of 33.8. Latest reported revenue was $25.84B, changing +8.5% year over year, with $3.73B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $341.18
- Day change
- +4.8%
- Market cap
- $124.86B
- P/E (TTM)
- 33.8
- Revenue growth
- +8.5%
- Industry
- Medical Devices